Hormonal and Clinical Effects of Ketoconazole in Hirsute Women
H. MARTIKAINEN,
J. HEIKKINEN,
A. RUOKONEN and
A. KAUPPILA
Departments of Obstetrics and Gynecology and Clinical Chemistry, University of Oulu Oulu, Oulu, Finland
Address all correspondence and requests for reprints to: Hannu Martikainen, M.D., Department of Obstetrics and Gynecology, University of Oulu, SF-90220 Oulu, Finland.
The effects of ketoconazole on pituitary-ovarian function andadrenal function were evaluated in nine hirsute women treatedwith 400–1200 mg/day for 1–6 months. High dose (800–1200mg/day) ketoconazole treatment decreased serum androstenedione,dehydroepiandrosterone, and testosterone (T) concentrations,while that of 17-hydroxyprogesterone increased, suggesting asteroidogenic block at the level of 17,20-desmolase. The decreasedserum T and increased sex hormonebinding globulin concentrationsled to a significant decrease in the free androgen index. Serumestradiol, cortisol, and dehydroepiandrosterone sulfate concentrationsdid not change. The serum LH concentration and the LH to FSHratio increased during treatment, suggesting a negative feedbackeffect of T on pituitary LH secretion. The hormonal changesthat occurred during high dose ketoconazole therapy persistedduring subsequent low dose (400 mg/day) treatment. The therapeuticeffect of ketoconazole on hirsutism manifested itself at 6 months.We conclude that ketoconazole reduces excessive androgen productionin a dose-dependent manner and decreases the free androgen indexin hirsute women; these changes are accompanied by significantalleviation of hirsutism.